COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?

COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?

Bibliographic Details
Main Authors:	Pugazhenthan Thangaraju, Meenalotchini Prakash gurunthalingam, Sajitha venkatesan, Eswaran Thangaraju
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	Journal of Infection and Public Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S187603412030472X

Similar Items

COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

COVID-19 and leprosy-hurdles and possible solutions
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

COVID 19'da N95 maskesinin yeniden kullanımı pandemik stratejiler ve ihtiyat
by: Pugazhenthan Thangaraju, et al.
Published: (2020-09-01)

Chloroquine induced utricaria—A detailed history helps
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
by: Pugazhenthan Thangaraju, et al.
Published: (2017-01-01)

News from regulatory corner: Safety communication and recent drug approvals
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Government of India initiative against leprosy—We should be aware
by: Sajitha Venkatesan, et al.
Published: (2019-01-01)

Cephalosporin's induced hepatic enzyme derangement - An educational report
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Single-dose rifampicin: What current World Health Organization guidelines emphasis and practical special attention?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

DSÖ lepra tedavi kılavuzu: farmakovijilansa odaklanma
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-06-01)

Medical residents: Research and publication priorities/confusions
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Cüzzamın yeniden alevlenmesine yönelik mücadele stratejileri: Vurgulanması gereken noktalar
by: Sajitha VENKATESAN, et al.
Published: (2019-12-01)

Responding to the Global Guidelines for the Prevention of Surgical Site Infection, 2018: A focus on surgical antibiotic prophylaxis prolongation
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Dünya Sağlık Örgütünün 2019'da küresel sağlığa tehdit ettiğini belirttiği on tehditten biri: Antimikrobiyal direnç
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-09-01)

Clofazimine induced methemoglobinemia –Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

De novo histoid leprosy - Further points of focus
by: Sajitha Venkatesan, et al.

Current treatment guideline by the World Health Organization against leprosy: A positive focus
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Leprosy in Children: Needs for Active Intervention
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Monotherapy with liraglutide – Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Vigilance in selection of low-dose versus high-dose steroids in COVID-19
by: Pugazhenthan Thangaraju, et al.
Published: (2021-08-01)

Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Ebola virüsüne yönelik ilaç çalışmaları: bir umut ışığı
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-12-01)

Named terminologies of patient-centered – A focus respective to stigmatized disease
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Curcumin and fungal infection – commonly available herbs for common female infection
by: Shoban Babu Varthya, et al.
Published: (2020-01-01)

Leprosy - the current target in national programmes
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Final leprosy push: Out of society
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Needs monitoring with quetiapine
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Violence against doctor – few points to be focussed
by: Pugazhenthan Thangaraju
Published: (2020-01-01)

First mobile application - Lepra reaction basic management guide - Stress on steroids
by: Pugazhenthan Thangaraju
Published: (2018-01-01)

Lepra tip 2 reaksiyonlarında talidomid tedavisinde ilaç yan etkisi olarak ikincil eosinofili: zorunlu bir sorumluluk
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-12-01)

Mycobacterium leprae or Tuberculosis: A diagnostic dilemma
by: Pugazhenthan Thangaraju, et al.
Published: (2017-01-01)

Retrospective analysis of drug prescription statistics in a tertiary care center in India: Recommendations for promoting prudent utilization of drugs
by: Ajaya Kumar Sahoo, et al.
Published: (2020-01-01)

To Act…….or to wait for the evidence: Ethics in the time of covid-19!
by: Durga Prasanna Misra, et al.
Published: (2020-01-01)

Sleep-walking a rarest side effect of zolpidem
by: Harmanjit Singh, et al.
Published: (2015-01-01)

Could This Be the Moment We Have Been Waiting For - Again?
by: Linda Stout, et al.
Published: (2021-04-01)

Safe Drugs Versus Innovative Drugs (Can We Have Both?)
by: Vera Lúcia Raposo
Published: (2020-05-01)

Right Bundle Branch Block: An Uncommon Cardiotoxic Manifestation of Hair Dye Poisoning-A Case Report
by: Deepak Balasubramanian, et al.
Published: (2014-01-01)

The role of etanercept in refractory erythema nodosum leprosum
by: Pugazhenthan Thangaraju, et al.
Published: (2016-01-01)

Nightmares and Mirtazapine—Time to be vigilant
by: Sree Sudha TY, et al.
Published: (2021-09-01)

Magnesium in drugs: do we have enough information?
by: Maria Ángeles Campos Fernández de Sevilla, et al.
Published: (2014-11-01)